Blood test detects 87% of early pancreatic cancers: What to know

A blood test correctly identified 87% of stage 1 and 2 pancreatic cancers, according to a study published Sept. 16 in Nature Medicine. For the study, researchers from Duarte, Calif.-based City of Hope tested the PANXEON liquid biopsy in nearly 1,800 patients across the U.S., Europe and Asia. The test identifies three biomarkers — circulating […] The post Blood test detects 87% of early pancreatic cancers: What to know appeared first on Becker's Hospital Review | Healthcare News &...

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.